Tag: antibody-drug conjugate
Correction Published for ABBV-706 Phase 1 Trial in Small Cell Lung Cancer and Solid Tumors
Nature Medicine has published an author correction to the ABBV-706 phase 1 trial, a SEZ6-targeting antibody-drug conjugate for advanced small…
Submit Your Paper to GMJ
No APC until January 2027.